Deborah Quaglio

Deborah Quaglio is a Researcher at the Department of Chemistry and Drug Technologies within Sapienza University of Rome. She holds a Bachelor's degree in Bioinformatics and teaches Organic Chemistry 2 in the Pharmacy and Medicine degree program (Classroom Psychology I, General Physiology and Anthropology, Code CU026, E01PSIL101). Her research focuses on synthetic organic chemistry, natural compound-based anticancer agents, and nanotechnology-enabled drug delivery systems.

• Key Research Areas:
  • Artificial resorcin[4]arene-based immunosensors
  • Natural product anticancer drug discovery
  • Polyamine linkers for active drug delivery
  • Antimicrobial resistance mechanisms
• Notable Scientific Contributions:
  • 2025 work on nanovehicles for colistin/ArnT inhibitor co-delivery
  • 2024-2025 studies on Hedgehog pathway inhibition in cholangiocarcinoma
  • 2023-2024 developments in resorcin[4]arene functionalized nanomaterials
  • 2022 investigations of Ferruginin A's antibiotic potential
• Collaborations:
  • Active member of the SYNLAB research group
  • Collaboration with European Cystic Fibrosis Conference initiatives

Her work bridges organic chemistry with biomedical applications, particularly in overcoming drug resistance and developing tumor-targeted delivery systems.